{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:06:52Z","timestamp":1778044012988,"version":"3.51.4"},"reference-count":34,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T00:00:00Z","timestamp":1271376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> To compare prophylactic enteral D\u2010penicillamine (DPA) with placebo for prevention of \u2018retinopathy of prematurity (ROP) or death\u2019 among very low birth weight (VLBW) infants.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> This was a double\u2010blind, single\u2010centre, randomized, placebo\u2010controlled trial with stratification (for birth weight &lt;1250 and \u22651250\u2003g) and blocking. Inborn neonates with birth weight 750\u20131500\u2003g, gestation \u226432\u2003weeks, age \u22645\u2003days, who tolerated feeds were eligible. Neonates with gastro\u2010intestinal malformations, life\u2010threatening malformations and necrotizing enterocolitis were excluded. Enrolled subjects were randomly allocated to receive oral DPA suspension at 100\u2003mg\/kg\/dose 8\u2003h for 3\u2003days, followed by 50\u2003mg\/kg\/day for another 11\u2003days or placebo. The primary outcome was \u2018any ROP or death\u2019. Secondary outcomes included any ROP, treatable ROP, adverse effects and feed intolerance.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> A total of 88 subjects were enrolled. Baseline characteristics were similar with the exception of multiple gestation. There were no significant differences in primary and secondary outcomes, even after adjusting for multiple gestation and on sub\u2010group analysis. No adverse reaction was noted.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Prophylactic enterally administered DPA suspension in a dose 100\u2003mg\/kg\/dose 8\u2003h for 3\u2003days, followed by 50\u2003mg\/kg once per day for next 11\u2003days, does not prevent \u2018any stage ROP or death\u2019 or \u2018ROP requiring treatment\u2019 in VLBW infants. DPA is well tolerated and does not have any major short\u2010term adverse effects.<\/jats:p>","DOI":"10.1111\/j.1651-2227.2010.01837.x","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T13:47:37Z","timestamp":1274104057000},"page":"1324-1328","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Oral D\u2010penicillamine for the prevention of retinopathy of prematurity in very low birth weight infants: a randomized, placebo\u2010controlled trial"],"prefix":"10.1111","volume":"99","author":[{"given":"Manjari","family":"Tandon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourabh","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mangat R","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amod","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(91)32074-8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100140452016"},{"key":"e_1_2_6_4_2","first-page":"1647","article-title":"Vascular endothelial growth factor. 20th\u2010century mechanisms, 21st\u2010century therapies","volume":"38","author":"Aiello LP","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/10715760410001684621"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/10623320214733"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:MCBI.0000044378.09409.b5"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001073"},{"key":"e_1_2_6_9_2","first-page":"47","article-title":"Controlled trial of D\u2010penicillamine to prevent retinopathy of prematurity","volume":"27","author":"Lakatos L","year":"1986","journal-title":"Acta Paediatr Hung"},{"key":"e_1_2_6_10_2","first-page":"9","article-title":"One year longitudinal follow\u2010up of premature infants treated with D\u2010penicillamine in the neonatal period","volume":"28","author":"Vekerdy\u2010Lakatos S","year":"1987","journal-title":"Acta Paediatr Hung"},{"key":"e_1_2_6_11_2","first-page":"459","article-title":"Neonatal oxygen toxicity and its prevention: D\u2010penicillamine offers benefits without harmful side\u2010effects","volume":"23","author":"Oroszlan G","year":"1982","journal-title":"Acta Paediatr Acad Sci Hung"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1980.tb07025.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000480988","article-title":"Age\u2010related difference in radioprotective effect of D\u2010penicillamine","volume":"5","author":"Lakatos L","year":"1982","journal-title":"Dev Pharmacol Ther"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01965582"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01990421"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198408233110817"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-198406000-00002"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(81)90465-7"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.2307\/3575844"},{"key":"e_1_2_6_20_2","first-page":"75","article-title":"The effect of penicillamine on the rabbit lung","volume":"105","author":"Caldwell EJ","year":"1972","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211440"},{"issue":"1","key":"e_1_2_6_22_2","first-page":"17","article-title":"D\u2010penicillamine \u2013 side effects, pathogenesis and decreasing the risks","volume":"47","author":"Grasedyck K","year":"1988","journal-title":"Z Rheumatol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(91)32350-9"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/48.4.239"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(84)34104-5"},{"key":"e_1_2_6_26_2","first-page":"123","article-title":"The incidence of retinopathy of prematurity in a neonatal care unit","volume":"43","author":"Charan R","year":"1995","journal-title":"Indian J Ophthalmol"},{"key":"e_1_2_6_27_2","first-page":"665","article-title":"Risk factors of threshold retinopathy of prematurity","volume":"41","author":"Dutta S","year":"2004","journal-title":"Indian Pediatr"},{"key":"e_1_2_6_28_2","first-page":"59","article-title":"Retinopathy of prematurity: a study","volume":"43","author":"Gopal L","year":"1995","journal-title":"Indian J Ophthalmol"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02830827"},{"key":"e_1_2_6_30_2","first-page":"211","article-title":"Incidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi","volume":"9","author":"Maheshwari R","year":"1996","journal-title":"Natl Med J India"},{"key":"e_1_2_6_31_2","first-page":"999","article-title":"Retinopathy of prematurity: incidence and risk factors","volume":"33","author":"Rekha S","year":"1996","journal-title":"Indian Pediatr"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3928\/0191-3913-19970301-08","article-title":"Retinopathy of prematurity in multiple\u2010gestation, very low birth weight infants","volume":"34","author":"Friling R","year":"1997","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"e_1_2_6_33_2","first-page":"327","article-title":"D\u2010penicillamine in the prevention of retrolental fibroplasia","volume":"23","author":"Lakatos L","year":"1982","journal-title":"Acta Paediatr Acad Sci Hung"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211653"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.02.018"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1651-2227.2010.01837.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1651-2227.2010.01837.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:13:42Z","timestamp":1697411622000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1651-2227.2010.01837.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,17]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1111\/j.1651-2227.2010.01837.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1651-2227.2010.01837.x","archive":["Portico"],"relation":{},"ISSN":["0803-5253","1651-2227"],"issn-type":[{"value":"0803-5253","type":"print"},{"value":"1651-2227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,17]]},"assertion":[{"value":"2010-08-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}